Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients
Clinical trial NCT03294486 · UNKNOWN
Trial details
- NCT number
- NCT03294486
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-12
- Primary completion
- 2019-05-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.